secwatch.observer — SEC 8-K summary
======================================

Issuer:     bluebird bio, Inc. (—)
CIK:        0001293971
Form:       8-K
Filed at:   2024-04-26T23:59:59+00:00
Accession:  0001293971-24-000014
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bluebird bio receives Nasdaq notice for late 10-K filing due to restatement
---------------------------------------------------------------------------

- Delayed 2023 Form 10-K due to restatement of 2022 annual and 2022/2023 quarterly financials.
- Restatements relate to identification of embedded leases and treatment of non-lease components.
- Company has until June 24, 2024 to submit plan to regain Nasdaq compliance; potential extension to Oct 14.
- No impact on cash position or revenue expected from restatements.
- Notice has no immediate effect on stock listing or trading.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1293971/000129397124000014/0001293971-24-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1293971/000129397124000014/blue-20240424.htm
  HTML page:      https://secwatch.observer/filing/0001293971-24-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer